NovoCure (NVCR) Projected to Post Earnings on Thursday

NovoCure (NASDAQ:NVCR) is expected to issue its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.34) per share and revenue of $161.30 million for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

NovoCure Stock Performance

NovoCure stock opened at $21.24 on Tuesday. The company has a current ratio of 1.49, a quick ratio of 1.44 and a debt-to-equity ratio of 0.27. The firm has a market cap of $2.30 billion, a P/E ratio of -15.17 and a beta of 0.62. NovoCure has a 1-year low of $11.70 and a 1-year high of $34.13. The firm has a 50-day moving average of $26.44 and a 200-day moving average of $21.40.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on NVCR shares. Evercore ISI upgraded NovoCure from an “in-line” rating to an “outperform” rating and increased their price objective for the stock from $18.00 to $30.00 in a report on Monday, December 2nd. Wedbush reaffirmed a “neutral” rating and issued a $29.00 price target on shares of NovoCure in a research note on Monday, January 13th. HC Wainwright reissued a “buy” rating and set a $38.00 price objective on shares of NovoCure in a research report on Tuesday, January 14th. Finally, Piper Sandler upped their price objective on shares of NovoCure from $28.00 to $42.00 and gave the stock an “overweight” rating in a report on Friday, December 13th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $32.67.

NovoCure Company Profile

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company’s TTFields devices include Optune Gio and Optune Lua.